MR-guided particle Therapy
Identify critical technicalities, evaluate solutions, proof of concepts design concept
The targeting accuracy of proton therapy (PT) for moving soft-tissue tumours is expected to greatly improve by real-time magnetic resonance imaging (MRI) guidance. The integration of MRI and PT at the treatment isocenter would offer the opportunity of combining the unparalleled soft-tissue contrast and real-time imaging capabilities of MRI with the most conformal dose distribution and best dose steering capability provided by modern PT.
Aswin Hoffmann et al. Radiat Oncol 2020 May 29;15(1):129. doi: 10.1186/s13014-020-01571-x

Figure2 from*
*”MRI-guided proton therapy combines two fast-growing technologies in radiation therapy. However, the integration of the two technologies is fraught with challenges.”
Trang Thanh Pham, B. Whelan, B.M. Oborn et al. Radiotherapy and Oncology 170 (2022) 37–47
DOI:https://doi.org/10.1016/j.radonc.2022.02.031
DETECTOR performed a feasibility study @HIT Heidelberger Ionenstrahl Therapiezentrum, in the context of HIT MR-PT Artemis project, in collaboration with Universitätsklinikum Heidelberg.
ARTEMIS concept rendering


Tentative achievements: Demonstrate the possibility of performing beam intensity estimation in the mentioned electromagnetically and acoustically noisy environment, with a good Signal to Noise Ratio and repeatability, paving the way of design and realization of a custom-built intensity monitor, as required in the ARTEMIS framework.
Feasibility goals:
- Transfer data under MR sequence
- Keep standards in particle detection
- Propose design solutions

Way to go :
- Study the scenario
- Adapt an IC + Lab test
- Onsite test
- Data analysis
- Custom design proposal
Four setups based on different MR machines were investigated, using a DETECTOR adapted intensity monitor chamber with external control unit. Two setups were placed in the HIT Experimental room, where 2, 0.2, 0.12 E9 protons per second @255-48 MeV/u have been extracted and delivered to the device under test while running either static magnetic field scan or MR-sequences.
ESAOTE, S-SCAN 0.25 T -proton detection-

Helmholtz coil 0-0.1 T -proton detection-

SIEMENS MAGNETOM SOLA 1.5 T CLINICAL ROOM -no beam-

MRIDIAN Linac 0.35 T CLINICAL ROOM -no beam-

General results
No data transfer interruption occurred
Preserved particle detection repeatability
Performance-improving design solutions detected
FOR
INFORMATION
INFORMATION
DETECTOR – Devices & Technologies Torino
Lungo Dora Voghera 36/A, 10153 Torino – Italy
Phone: +39 011 19 010 766
Fax: +39 0110133009
Email: info@detector-group.com
Con la presente si informa che i dati raccolti verranno esclusivamente utilizzati all’interno della banca dati di DE.TEC.TOR.. La persona autorizza la DE.TEC.TOR. ad usare i suoi dati per inviare eventualmente materiale informativo riguardante le attività o qualsiasi iniziativa dI DE.TEC.TOR.. I dati non saranno per nessuna ragione divulgati o ceduti a terzi senza una Sua esplicita autorizzazione. I dati personali che Vi riguardano non saranno utilizzati a fini di invio di materiale pubblicitario commericiale o di vendita diretta o per il compimento di ricerche di mercato o di comunicazione commerciale. In ogni momento, ai sensi dell’art.7 del D.lgs.196/2003 e del Regolamento Europeo 2016/679, potrà consultare, modificare o chiedere la cancellazione di tali dati scrivendo a: DE.TEC.TOR. – Lungo Dora Voghera 36/A, 10153 Torino – Italy